Synergistic Effects of Ethanolic Extract of Ocimum Sanctum and Omega 3 Fatty Acid on Mice Infected With Plasmodium Berghei
Author(s)
Haruna Yusuf , I.O Obaroh , D.D Attah , A. Aisha , A. L Hafsat , M. M Galamaji ,
Download Full PDF Pages: 44-56 | Views: 1288 | Downloads: 343 | DOI: 10.5281/zenodo.3483341
Abstract
This study was carried out to investigate the synergistic effect of ethanolic extract of Ocimum sanctum and Omega 3 fatty acids on mice infected with P. berghei. The parameters analyzed include a qualitative phytochemical screening of Ocimum sanctum, toxicity study of LD50 of O. sanctum, level of parasitaemia rate after treatment, Biochemical indices and enzymes assays. All parameters were analyzed using the standard method of analysis. The qualitative phytochemical screening of O. sanctum shows high present of volatile oils, and moderately presence of saponins, steroids, cardiac glycoside, and alkaloids, with low presence of flavonoids, Tannins and Antraquinone were absent. Acute toxicity of LD50 of Ocimum santum was established at 1,936.49mg/kg. Group F (standard control) and a group of Mice that administered with 300mg/kg + 0.2 cod-liver oils had the highest significant (P<0.05) inhibition rate of parasitaemia (P<0.05) while Positive control group (infected and untreated)had lowest significant (P<0.05) inhibition rate. The synergy of Ocimum sanctum and cod-liver oils shows significant (p<0.05) increase in Biochemical indices while group F ( standard control) and group A (infected untreated) shows significant (P<0.05)decrease in Biochemical indices. The combination of Ocimum sanctum and cod-liver shows significant (p<0.05) decrease in enzymes assays at different concentration while infected untreated group shows a significant increase in enzymes assay .The study indicates that the combination of Ocimum sanctum and Omega 3 fatty acids at different concentration show anti-malarial effects. Damage done to the liver is minimal as indicated in the enzymes assay. Thus the combination of Ocimum sanctum and Omega 3 fatty acids can be used as anti-malarial
Keywords
Ocimum santum, Omega 3 fatty acid, Plasmodium berghei, Enzyme assay, Biochemical indices, Phytochemical
References
i. Adebayo, J.O Adeleke,A.C, Akintunde,O.N.( 2014).In vivo Antiplasmodium potential of plantNauclea latifolia.Journal of Molecule.19 13136-13146.
ii. Adebayo, J.O and Krettli, A.U. (2010). Potential Anti-Malaria from Nigerian Plants. Journal of EthnoPharmacology.13 (2):289-302.
iii. Aherne, S. A., Daly, T. Connor, T. and Brien, N. M. (2007): Immmunomodulatory effects of β-sitosterol on human jurkat T cells. Planta Med., 73 (9): 797-1034.
iv. Ahmed, M., Ahamed, R.N., Aladakatti, R.H, Ghosesawar, M.G.(2002).Reversible anti-fertilitity Effect of benzene extract of Ocimum sanctum leaves on sperm parameters and fructose Content in rats. Journal of Basic clinical physiological pharmacology,Vol 13(1):51-9
v. Ambekar, M. V., Lalit M., Meena K. (2011) Ocimum sanctum (Tulsi) An overview. Journal of International Science Review:7(9) 0976-044.
vi. Arise, R. O., Malomo, S. O. and Lawal, M. M. (2012): Comparative antimalarial and toxicological effects of artemisinin with methanolic extract of Carica papaya leaves and bark of Altoniabroonai in animal models. Adv.Natl.Applied Sci., 6:116-123.
vii. Arora, A, (2014): A text of book of Medical, Parasitology fourth edition.Pp81-239
viii. Ayodele, J., Oluyemi, S., Amos, P. and Tuoyo, O. (2007) Quantifying the Economic Burden of Malaria in Nigeria using the Willingness to Pay Approach.Cost Effective Resources Allocation. Retrived on 2007 at http://www:research gate.net/…/6315781
ix. Bansod, S., Rai, M. (2008). Antifungal Activity of Essential oil from Indian Medicinal plant Against Human pathogenic Aspergillus fumigatus and A.niger. World Journal of Medical Sciences: 3 (2):81-88.
x. Banyal, H.S., Kumar, S., Upam.A. (1991). The course of Plasmodium berghei strains mice. Biove.,1.197 - 200
xi. Banyal, H.S., Raksha, S., Nisha. D. (2015). Antimalarial of Ocimum sanctum and Bauhinia variegate.Journal of Pharmacy Biological Science:10 (2):70-72.
xii. Bartholomew, R. and Delany,A.N. (1998). Determination of Serum Albumin. Proceedings of The Australian Association of Clinical Biochemistry 1:64
xiii. Bunza, M.D.A. (2010).Protozoa of Medical and Vertinary Importance.First published 2010 by: Pylar mak Publishers. pP 106-108.
xiv. Carter, R., Drakeley, C. (2011).The Biology of sexual development of plasmodium, the design and implementation of transmission blocking strategies Malaria Journal of bio med. Central.com.:8:Pp192-223.
xv. Centre for Disease Control and Prevention (2002). History of Malaria an Ancient Disease Retrived on 2003 at www.cdc.gov/malarialhistory/index.htm.
xvi. Centre for Disease Control and Prevention (2004). Malaria Facts: Frequently Asked Questions Retrived 2004 at www.cdc.gov/malariahistory/index.htm.
xvii. Centre for Disease Control and Prevention (2008). Combating malaria and Parasitic Disease Through Vector Control.Retrived on 2008 atwww.cdc.gov/malaria/control/prevention/vector/control.htm.
xviii. Chiag,L.C, Ng L.T, Cheng P.W, Chiag W., Lin C. (2005). Anti-viral activities of Ocimum basilicum.Clinical and Experimental Pharmacology and physiology. 32 (10):811-816.
xix. Dondee, K.D, Borkaew. P.B, Klubsri.C.K, Butsara.P.B, Somsak, V.S (2016). The effect of
xx. Moringa oleifera leaf extracts on liver damage in mice infected with plasmodium beighei,Journal of Costal LifeMedicine:4(9): 742-746.
xxi. Doumas, B. T and Biggs, H. G. (1997). Standard Methods of Clinical Chemistry. Academic Press New York. Vol. 7 pP. 1-175
xxii. Edith, A.,Mofolusho,F.,Omonike,O., Larry,O.and Dora,A.(2006).In vivo Anti-malarial and Cytoxotic Properties of Annona Snegalensis Extract.African Journal of Traditional, Complementary and Alternative Medicine:.3 (1): 137-141.
xxiii. Evangeline, T., Oparocha, Okorie, C. (2009). In vivo evaluation of anti-malarial activity of three Medicinal plant used in South Eastern Nigeria.Journal of Herbs, species and Medicinal Plants.15(1):121-128.
xxiv. Ezeonwumelu, L.O.C, Omolo, R.G., Ajayi, A.M, Agwu, E., Tanayen, J.K, Adiukwu, C.P., Oyawole, A.A., Adzu, B., Okoruwa, A.G., and Ogbonnia, S.O. 2006. Studies of phyto
a. Chemical screening, acute toxicity and anti-diarrhoel effect of aqueous extract of Kenyan Tithonia diversifolia leave in rats.British Journal of pharmacology and Toxicology,3:(3):127-134.
xxv. Gbadamosi, I. T., Moody, J. O. and Lawal, A. M. (2011): Phytochemical screening and proximate analysis of eight ethnobotanicals used as antimalarial remedies in Ibadan. Nig. Journal. Appl. Biosci. 44:2967-2971.
xxvi. Greenwood, B. and Mutabingwa, T. (2008). Malaria in 2002.Nature 415:670-672
xxvii. Gupta, S.KPrakash, J., Srivastava, S.V. (2002). Validation of claim of Tulsi, Ocimum sanctum Linn as medicinal plant.Indian Journal of Experimental Biology 40: (7):765-773.
xxviii. Heingard, D. and Tiderstorm, G. (1997). Determination of Serum Creatine by a Direct Colorimetric Method.Clinical Chemistry Acta.43:305-7
xxix. Igile, G.O.(1995).Phytochemical and biological studies on some constituents ofAmygdalina (Compositae) leave. Ph.D Thesis, Department of Biochemistry, University ofIbadan,
a. Nigeria.
xxx. Jacometo,T.J,Castilho,D.E.,Anotonio,V.S.(2015)Healing process of colonic Anastomosis :.28(4):258-26 doi:101590/50102-67202015000400 PMCID:PMC4755178.S
xxxi. Johnson, W.E, Cibulskis, Stekette, R.W. (2010). Malaria funding and resource Utilization: First decade of Roll back Malaria World Health Organization. (2) 224 – 226.
xxxii. Jude, E., Okokon, Ettebong, E.E and Bassey, S., Anita (2008). In vivo Anti-Malarial Activity of Ethnolic Leaf Extract of Stachytarpheta Cayennensis. Indian Journal of Pharmacology .40 (3): 111-113
xxxiii. Kent, M.K. (2000). Advanced Biology Oxford, First Edition Pp 324 – 325
xxxiv. Khann, N., Bhatia, J. (2003) Action of Ocimum sanctum (Tulsi) in mice possible mechanism Involved. J. of Ethnopharmacology:88(2-3) 293-296.
xxxv. Klein EY. Antimalaria drug resistance: A review of the biology and strategies to delay
a. emergency and spread. Int Journal of Antimicrob Agents (2013,)
b. http://dx/dl.org/10.1016/j.ijantimicag.2012.12-007
xxxvi. Krafts, K., Hempelmann, E., Oleksyn, B. (2011) The color purple: from royalty to laboratory, with apologies to Malachowski. Journal of Biotech Histochem. 86 (1): 7–35.
xxxvii. Kolapo, A. L, Okunade, M. B., Adejumobi, J. A and Ogundipo, M. O (2000). Phytochemical Composition and Antimicrobal Activity of Prosopis African against some selected oral pathogens. World Journal of Agricultural Science5 (1):90-93
xxxviii. Kumaratilake, L., Chin, I.V, (1992). A recent thesis from French CNRS confirms, sample record for strong adipocyte expression Journal of PUFAS:9:pP345-387.
xxxix. Lutgens, P. (2016). The strong prophylactic and anti-malaria properties of polyunsaturated fatty acid (PUFAS) Retrieved on 13-02-2015. https//malariaworld.org/…/st…
xl. Lorke D.A, (1983). New approach practical acute toxicity testing Archy Toxicology :54:275 – 87.
xli. MacDonald, I. (2009) .The Plant Called Medicine: An Inaugural Lecture Series of the University of Benin, Benin City, on Plant Biology and Biotechnology. Pp. 1-3
xlii. Makkar.H.P.S. (2003).Effects and Fate of Tannins in Ruminant animals, adaptation to tannins, and strategies to overcome detrimental effects of feeding tannin rich feeds. Small Ruminant Research 49:241-256.
xliii. Mark, F. W (2000): Cellula and Molecular Biology of Plasmodium Parasite. Tuslane UniversityOnline.Pp.1-34 Retived on 2001 at http://www.tulane.edu/~wiser/protozoology/notes/pl-sp.html
xliv. Matur, Bernard, Malau, Mthew, T. and Ifenyi, Casmir, I.C. (2009) Analysis of the
a. Phytochemical and in vivo Anti-malaria Properties of Phyllandthus Fraternus Webster.New York Science Journal..2 (5): 12-19
xlv. Moran, M. (2009) Finder: Neglected Disease Research development, Pp 60 –65.
xlvi. Murray, R.P. (2000) Reading Medical Microbiology: Micro Biology and Immunology on line. 6th edition Pp.960of Greenmediinfo.com.
xlvii. Olivera, F.A., Viera-junior, G.M., Chaves, M.H., Almeida, F.R.C., Florencio, M. G., Lima, Jr R.C.P., Silva, R.M., Santos, F.A., and Rao, V.S.N.2004. Gastro-protective and inflammatory effects of resins from Protium heptaphyllum in mice and rats J. pharmacological research, 49:105-111.
xlviii. Olubunmi, .O.O. (2013).Parasites of Man and Animal.Published by concept publication limited.193-215.
xlix. Olubunmi.O.O. (2013). Element of Parasitology Third Edition, published by panafpublishing inc.978-981..
l. Oyewole, I. O. Ibidapo, C.A.; Moronkola, D.O., Oduola, A.O., Adeoye, G.O., Anyasor, G.N and Obansa, J.A. (2008).Anti-Malaria and Repellent Activities of Tithonia diversifolia (Hemsl.) Leaf extracts. Journal of Medical Plants Research.2: (8): 171-175
li. Palmer, J.O, Sam, T. (1999) Hematology, Morphology Binder,Broadsheet Recommendations for For Examination of Blood film for malaria parasite. 3(4.3):1-4..
lii. Pandey, B.P and Anita (1990). In: Economic Botany published by Chand and company Ltd.,
a. Ramnagar, New Delhi 294.
liii. Peters, W., (1970). Chemotheraphy and drugs resistance in malaria Academic Press London, 1: 111:133.
liv. Prashant, P.T., Bimlesh, B.K, Mandeet, M.K., Gurpreet, G.K, Harleen,H.K (2011).phytoche
a. Mical Secreening and extraction.Journal of pharmaceutical Science peer Reviewed 1(1) 98-106.
lv. Prassanna, P. (2009). Malaria Aneamia and Nitric Oxide Induced Megaloblastic anemia: A
a. Review on The Cause of Malaria Anemia. Journal of Vector Borne Disease:46 :100-106.
lvi. Redd, S., Kazemba,P., Luby S., Nwanyaw, O, Hightower,A., Ziba, C. Wirima, J., Chitsulo,
a. L., Frango, C., Oliver, M.(2006). Clinical algorithm treatment of plasmodium falciparum malaria in children. :347: 8996-80.
b. Reitman, S. and Frankel, S. (1957): A colometric method for determination of serum glutamate oxaloacetate and glutamic transaminase. Am. J.Clinical pathol .vol28: 56-58.
lvii. Robert E. Sinden , Geoff A., Beetsma A.L (2002). Malaria Methods and protocols:Maintenance of Plasmodium berghei life cycle. Methods in Molecular Medicine.Journal ofMolecularMedicine:72:25-26.
lviii. Robinson, P. (2012).Health Benefits of Omega 3 fatty Acids.Journal of PUFAS derived from
a. Phospholipid exert a potent in vitro anti-Plasmodium vol:10: pP 1371-5990.
lix. Roy A.V (1970).Determination of Serum Alkaline Phos phatase. Clinical Chemistry 16:431-
a. 433.
lx. Sen, P. Therapeutic potentials of Tulsi from experience to facts. Drugs news view, (1993).1
a. (2): 15-21.
lxi. Senior, K. (2008). Shortfall in front-line anti-malaria drug likely in 2005.5:(2):75-80.
lxii. Schumann, J.(2011). Extensive review describe how PUFAS Might affect sporozoites invasionJournal of PUFAS vol: 6 (1)24-66,
lxiii. Snow, R.W., Guerra, C.A., Noor, A.M., Myint, H.Y, and Hay, S.I. (2005). The Global
a. Distribution of Clinical Episodes of Plasmodium falciparum Malaria Nature:434 (7030): Pp214-217.
lxiv. Temitope, A. (2016). The Effect of Momodica charantia leaves on haemoglobin concentration in male Albino rat International Blood Research & Reviews 2:(2): pP82-86,
lxv. Tiago, Carlos, L.C, and Eneri.( 2015). Effect Of Omega – 3 Fatty Acid PUFAS derived from human phospholipids exert a potent in vitro anti-plasmodium activity Journal of Poly unsaturated Fatty Acids8 Pp 90-99.
lxvi. Tinto, H., Rwagacondo, C., Karema, C. (2006).In vitro susceptibility of plasmodium falciparum To monodesetly lamodiaquine, dihydroartemsinin and quinine in an area of high Chloroquine resistance in Rwanda. Transaction of the
lxvii. Royal society of Tropical Medicine Hygiene 100 (6):509-11.
lxviii. Warhust, D.C., William, J.E(1996).Laboratory diagnosis of malaria.Journal of Clinical Patholog 49:533-38.
lxix. Walter. R. (2002): Biosystematics Unit Mosquito Occurrence Dataset. Global Biodiversity Information Facility.www.gbif.net/species/browse/
lxx. Weatherburn, M. W. (1996). Analytical Chemistry 39:971
lxxi. White, N.J (2004). Anti-malaria drug resistance. Journal of Clinical Investigation:113 (8):1084-1090
lxxii. World Health Organization (2002).Reducing Risk, Promoting Healthy Life. Retrived at www.who.int/whr/2002/en
lxxiii. WHO and UNICEF (2005): WorldMalaria reportRetrived on http://whqlibdoc.who.int/publication/2005/924593199-eng.pdf
lxxiv. World Health Organization (2004).. Treatment of Mosquito Nets for Malaria Vector Long
a. Lasting Insecticide treated Nets.Retrived atwww.who.net/whr2004.
lxxv. World Health Organization (2007): Malaria fact sheet N0 94 Retrived atwww.who.net/whr/2007
lxxvi. World Health Organization (2008): World Malaria report. Retrived at www.who.net/ whr/2008
lxxvii. World Health Organization (2015): World Malaria report Retrived on 2015 at.www.who .net/who.int/malaria/publication/world. .
lxxviii. World Health Organization (2016).World malaria report Retrived on December 2016 at http://www.who.int/malaria/publications/world.
lxxix. World Health Organization (2017) Date Accessed Malaria Vaccine Rainbow Retrived on 17, July 2017. athttp://www.who.int/vaccie research/link/en/index.html.
lxxx. Yakubu, M. T., Adebayo, J. O., Egwim, E. C., and Owoyele, B. R. (2005): Increased liver Alkaline phosphatase and amino transferase activities following administration of
a. Ethanolic extraction ofKhaya senegalensis stem bark on rat.Biochemist, 17(1):27-32.
lxxxi. Yang, J.L and H.C. Chem, (2003). Serum metablic enzymes activities and Hepatocyte Ultra Structure of common carp after gallum exposure.Zoological Studies, 42: 455-461.
lxxxii. ZVED- National Centre for Zoonotic, Vector-Borne and Entric Diseases (2004). Malaria. Division of Parasitic Diseases.Retrived at www.ncz.net/zved/2004
Cite this Article: